All Articles

Rosenberg & Parker's new Financial Institutions Practice, led by Nathan Hummel, signals a major shift in how banks manage risk and capital.

Small biotech Veru Inc. is betting its future on improving blockbuster weight-loss drugs, targeting the hidden cost of muscle loss in a billion-dollar market.

A novel partnership aims to create the first drug for ReNU syndrome, a condition found in 2024, potentially redefining rare disease drug development.

DBGI announced a massive program expansion, but a recent stock split, weak financials, and a fight against market anomalies paint a complex picture.

Catalogic's latest DPX release adds agentless Proxmox protection and deepens cyber resilience, a strategic move to unify data management in a fragmenting IT world.

Matrix Adhesives' strategic acquisition of IPS Adhesives, backed by TruArc, signals a major play for global market share and advanced technology leadership.

In a world where downtime costs millions, Sunlight Batteries USA's new Quick Ship Program promises a 24-hour fix. Is this the future of supply chain resilience?

Paragon Bank's dividend signals more than financial health; it's the result of a unique growth model fueled by an award-winning culture. Here's how.

A $24.3M loan for a Utah retail property reveals more than a financial deal. It's a look at how some communities are building resilient local economies.

A strategic investment in RH Aero Systems by Capitol Meridian Partners isn't just a deal; it's a move to fortify the critical, unseen infrastructure of global flight.

With its transformation to a pure-play tech firm complete, Altus Group brings in a new CFO to hit aggressive growth targets and harness the power of AI.

Veteran strategist Rashad Robinson's new book offers a tactical guide for moving beyond protest to dismantle consolidated corporate and tech power.

C&S Wholesale Grocers' deep price cuts offer shoppers relief, but behind the bargains lies a strategic gambit that could reshape the Midwest's competitive landscape.

With a massive global study and powerful data analytics, Seegene aims to prove its new combined HPV/STI test can unmask silent co-infections and set a new standard.

With a new CMO and fresh funding, Spero Therapeutics is betting big on its immunology asset SP001. Can Dr. Zack guide it to success in a competitive field?

Slovakian battery innovator InoBat is going public via a SPAC deal, aiming its advanced energy storage at the insatiable power demands of AI and data centers.

The appointment of M&A expert La Vonda Williams to a strategic review committee isn't just a personnel change; it's a clear signal to Wall Street.

Grupo Financiero Atlántida launches NYC-based BancAtlantic, led by John Tonelli, to fill a capital gap in overlooked emerging markets. A strategic masterstroke?

Geospatial leader ProStar appoints Michael Wolff to transition from founder-led innovation to global market dominance in critical infrastructure mapping.